[Presentation Report] The Antimicrobial Resistance Summit Asia (December 5, 2019, Singapore)
date : 12/17/2019
Tags: AMR
On December 5, 2019, Health and Global Policy Institute (HGPI) CEO and Board Member Mr. Ryoji Noritake attended the Antimicrobial Resistance Summit Asia held by The Economist in Singapore.
Antimicrobial Resistance, or AMR, refers to the phenomena by which bacteria become immune to antimicrobial treatments over time as those treatments are used more and more. Infectious diseases brought on by antimicrobial resistant bacteria can be difficult to treat, and can even be fatal in worst case scenarios.
The problem of AMR is worsening across the world. If current trends continue, it is estimated that by 2050, as many as 10 million people could potentially die of AMR-related causes globally every year.
Mr. Noritake spoke at the panel discussion on AMR and the Sustainable Development Goals in Asia. His remarks included an introduction of the activities of AMR Alliance Japan, established in November 2018 by HGPI and key infectious disease stakeholders in Japan.
AMR Alliance Japan has worked with Alliance members and partner organizations to deepen policy debate around AMR. This work resulted in the July 2019 release of “AMR Alliance Japan Policy Recommendations: The Japanese Government’s Role in Promoting AMR Countermeasures.” Moving forward, the Alliance will take every opportunity to explain these recommendations to AMR policy stakeholders toward concrete policy action on AMR.
HGPI has hosted a number of meetings related to AMR over the past few years. HGPI is committed to promoting further, healthy debate on this pressing global issue.
日本語
Top Research & Recommendations Posts
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Global Climate and Health Alliance (March 23, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-01
[Registration Open] The Global Health Education Program (G-HEP) 2024 (May 1, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session